🔎 Trials Near Me

Akèy › Depresyon › Kalifòni › Orange

Etid klinik pou Depresyon nan Orange, CA

9 etid pou Depresyon ap chèche patisipan nan sit nan ak bò kote Orange (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 2
  • Nrc Research Institute, Orange
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07621237

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Ap rekriteFaz 3
  • ATP Clinical Research, Orange
  • NRC Research Institute, Orange
Laj 18 a 85 · Tout sèks · Mizajou Sep 25, 2026 · NCT06793397

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

Ap rekriteFaz 3
  • ATP Clinical Research, Orange
Laj 18 a 75 · Tout sèks · Mizajou Aug 6, 2026 · NCT07412756

E-Mindfulness Approaches for Living After Breast Cancer

Ap rekriteFaz 3
  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Laj 18 a 50 · Tout sèks · Mizajou Aug 4, 2026 · NCT06748222

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Ap rekriteFaz 3
  • Atp Clinical Research, Orange
  • Nrc Research Institute, Orange
Laj 18 a 74 · Tout sèks · Mizajou Aug 3, 2026 · NCT06775379

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Orange
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06966401

TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age

Ap rekriteEtid obsèvasyon
  • Children's Hospital of Orange County, Orange
18 Months – 11 Years · Tout sèks · Mizajou Jul 6, 2026 · NCT07048574

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Orange
Laj 18 ak plis · Tout sèks · Mizajou Oct 29, 2025 · NCT06786624

Etid Depresyon nan lòt vil

Lòt etid nan Orange

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.